Omnimmune (OMMH) Inactive 10-Q2010 Q1 Quarterly report

Filed: 24 May 10, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: accommodate, ach, acquiesce, adjustment, Ag, agreeme, angel, antigen, ass, ayment, ba, bifurcation, category, challenging, Chassman, cial, climate, Committee, condensed, COSO, creditor, disappeared, ed, EITF, embedded, en, equivalent, ertain, exacerbate, exempt, exemption, expended, extent, extinguishment, filer, finan, fixed, fourth, free, fully, genomic, greater, greatly, harm, Health, hourly, ieve, initial, input, instrument, iod, irreparably, leakage, leaving, maintain, maintaining, Margie, million, misstatement, modification, nts, observable, pat, Penn, permit, po, proh, prototypical, prove, recoverabilit, reement, responsible, round, Rule, sed, settlement, similarly, situated, situation, sought, st, sult, survive, techno, threshold, traditional, Treadway, treated, type, unobservable, urance, voluntary, warrant, weak, West, worsen

Removed: agree, certainty, circumvented, collaboration, collusion, compliance, delay, deteriorate, director, error, faulty, forthcoming, fraud, genetic, hCGb, Hospital, inadequate, individual, invoice, level, long, mistake, multivalent, mutually, NCI, necessarily, override, people, recoverability, request, resource, simple, sponsor, sponsored, succeed, utilized

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

OMMH similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Harris A. Lichtenstein, Ph.D., the President, Chief Executive Officer and Director of Omnimmune Holdings, Inc. certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Quarterly Report on Form 10-Q of Omnimmune Holdings, Inc. for the period ended March 31, 2010 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Omnimmune Holdings, Inc.

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

Date:	May 24, 2010

Signature:	/s/ Harris A. Lichtenstein, Ph.D.
	Name: Harris A. Lichtenstein, Ph.D.
	Title: President, Chief Executive Officer and Director Omnimmune Holdings, Inc.

A signed original of this written statement required by Section 906 has been provided to Omnimmune Holdings, Inc. (F/K/A Roughneck Supplies, Inc.) and will be retained by it and furnished to the Securities and Exchange Commission or its staff upon request